Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$720,311
+$538,883 QoQ
Shares Held
51,821
+294.2% QoQ
Ownership
0.085%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Engineers Gate Manager LP holds $239,142,110 across 145 Biotechnology names. JANX ranks #56 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
158,792 | $25,965,667 | |
| 2 | BMRN |
Biomarin Pharmaceutical Inc
|
436,860 | $24,678,221 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
243,729 | $18,099,315 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
92,990 | $17,579,759 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
32,502 | $10,753,936 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
133,827 | $10,049,069 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
254,401 | $7,558,253 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
256,447 | $7,103,581 |
All Filings in JANX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $720,311 | 51,821 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $181,428 | 13,147 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $217,907 | 8,916 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $918,201 | 39,749 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $499,257 | 18,491 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $286,546 | 5,352 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $294,193 | 7,023 | Shares | Sole | 2024-08-14 | |
| No filing history on record for this holder in this stock. | ||||||